Filing Details

Accession Number:
0001022079-22-000152
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-02 16:32:25
Reporting Period:
2022-11-01
Accepted Time:
2022-11-02 16:32:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1204666 M Timothy Ring 500 Plaza Drive
Secaucus NJ 07094
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-01 260 $61.23 24,193 No 4 M Direct
Common Stock Acquisiton 2022-11-01 1,371 $60.79 25,564 No 4 M Direct
Common Stock Acquisiton 2022-11-01 369 $62.01 25,933 No 4 M Direct
Common Stock Disposition 2022-11-01 2,000 $144.06 24,149 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2022-11-01 260 $61.23 260 $61.23
Common Stock Stock Options (Right to Buy) Disposition 2022-11-01 1,371 $60.79 1,371 $60.79
Common Stock Stock Options (Right to Buy) Disposition 2022-11-01 369 $62.01 369 $62.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-05-21 No 4 M Direct
0 2013-07-01 2023-07-01 No 4 M Direct
972 2013-10-01 2023-10-01 No 4 M Direct
Footnotes
  1. The amount includes approximately 216 shares acquired via dividend reinvestment pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
  2. Options vested in three equal annual installments beginning on the first annual anniversary of the grant date.